Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000307169 ("novel transcript, antisense to LTA4H," "LOC124902990") is a long non-coding RNA gene located antisense to the protein-coding gene LTA4H (leukotriene A4 hydrolase)[5]. Unlike LTA4H, which encodes a zinc-dependent enzyme involved in leukotriene B4 biosynthesis and inflammatory pathways[1][7], this transcript does not code for a protein and has no known direct function or role in disease. Its presence may indicate a potential regulatory relationship with LTA4H, but as of current knowledge, it is not characterized as a functional or therapeutic molecular target, nor is it implicated in pharmacology or used as a biomarker. If structured information about LTA4H itself (the protein) is needed, this is a distinct, well-characterized enzyme involved in pro-inflammatory mediator synthesis[1][3][7]; however, ENSG00000307169 refers to an uncharacterized antisense lncRNA gene adjacent to LTA4H and not the enzyme itself[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to leukotriene A4 hydrolase.